This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation, Ahead of Print. The use of some types of these products, for instance, is associated with an increased mortality risk in those with ischemic heart or cerebrovasculardisease.
Among other potential contributors to atheroma formation and cerebrovasculardisease, the gut microbiome has become increasingly implicated as a mediator of vascular risk. Several of these toxic metabolites, including trimethylamine and trimethylamine Noxide, have been extensively studied in cardiovascular and cerebrovasculardisease.
Introduction:Moyamoya is a progressive cerebrovasculardisease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. The median time from diagnosis was 0 years (IQR 0, 1.3).
Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovasculardisease with unknown etiology and pathogenesis. Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved.
Background:Our recently reported that patent foramen ovale (PFO) shunt enables the elevation of total homocysteine (tHcy) in patients circulation (Deng, Neurology 2021). Stroke, Volume 56, Issue Suppl_1 , Page AWP394-AWP394, February 1, 2025. However, the underlying molecular mechanism of how tHcy causes PFO-related injury is unclear.
Introduction:Intracranial aneurysm (IA), a cerebrovasculardisease affecting 3-5% of US population, leads to subarachnoid hemorrage. This demonstrates the potential of using circulating blood to screen for IA presence. Stroke, Volume 56, Issue Suppl_1 , Page A78-A78, February 1, 2025.
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovasculardisease, and peripheral vascular disease (inclusive of aortic aneurysm).3
BackgroundBrain arterial diameters (BADs) are novel imaging biomarkers of cerebrovasculardisease, cognitive decline, and dementia. Brain arterial diameters for 13 segments were measured and averaged to obtain a global measure of BADs as well as the posterior and anterior circulations.
Multivariable linear regression was used to assess the association between circulating markers of inflammation with internal carotid artery (ICA) CIMT. Multivariable linear regression was used to assess the association between circulating markers of inflammation with internal carotid artery (ICA) CIMT.
Image courtesy: ASA/AHA christine.book Mon, 01/22/2024 - 18:03 January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovasculardiseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024 , will be held Feb. 7-9 in Phoenix, Arizona.
Sacco Outstanding Stroke Research Mentor Award recognizes outstanding achievements in mentoring future generations of stroke researchers in the field of cerebrovasculardisease. The Ralph L. Chimowitz will present his lecture, “Mentoring Clinical Stroke Researchers in Challenging Times,” on Feb. McCullough, M.D., Siekert, M.D.,
Anticardiolipin antibodies, anti-2-glycoprotein I antibodies, and lupus anticoagulant were assessed using the guidelines of the International Society on Thrombosis and Haemostasis.RESULTS:aPL prevalence was 22% in patients with MMA and 25% in controls (P=0.74) with no differences in aPL subtypes between the 2 groups.
Circulation, Volume 150, Issue Suppl_1 , Page A4140005-A4140005, November 12, 2024. They increase the risk of hypertension, coronary artery disease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiac arrest, and stroke. decline in overall CVD mortality rates (Table). AAPC, compared to a 3.1%
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Cardiovascular disease (CVD) is among the costliest conditions in the United States, and cost-effectiveness analyses can be used to assess economic impact and prioritize CVD treatments.
Introduction:Visual impairments occur frequently in patients with cerebrovasculardisease, particularly with carotid artery disease, which contributes to the development of vascular contributions to cognitive impairment and dementias (VCID).
Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovasculardisease. Circulation.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content